GlassScriptPhysician profile
Terah Isaacson
NPI 1023220316
$6,502.60
in general payments reported to CMS, 2019-2025
12 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,884 · 2020: $107 · 2021: $2,040 · 2023: $45.61 · 2024: $225 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246 · Gift: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.26 |
| Gift | $225.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $5,904.87 | 2019-2021 | |
| Kerecis Limited | $225.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Canon Medical Systems USA, INC. | $200.65 | 2025 | Interventional Angiography System |
| Davol INC. | $32.34 | 2020 | |
| Covidien LP | $24.63 | 2020 | |
| Baudax Bio INC. | $24.28 | 2021 | |
| Boston Scientific Corporation | $23.67 | 2023 | Resolution 360 Clip |
| Convatec INC. | $21.94 | 2023 | |
| Ferring Pharmaceuticals INC. | $16.80 | 2019 | |
| Coopersurgical, INC. | $16.11 | 2021 | |
| Ethicon US, LLC | $12.04 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,706.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terah Isaacson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.